This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Dr. Masayuki Sugimoto, PhD
Manager at Nitto Denko Corporation
Speaker

Profile

Masayuki Sugimoto is a Group Manager of Nucleic Acid Medicine Business Division at Nitto Denko Corporation. Dr. Sugimoto received his Ph.D. in Medicine from Hokkaido University in 2016. Prior to Nitto Denko Corporation, he researched at Japanese pharmaceutical company in Japan for 13 years and Sanford Burnham Prebys Medical Discovery Institute in the US for one year. After he joined Nitto Denko Corporation in 2021, Dr. Sugimoto has been working on development of nucleic acid medicine and delivery for liver diseases.

Agenda Sessions

  • Nitto Bispecific siRNA Targeting YAP1/WWTR1 As A Novel Therapeutic Agent for Liver Fibrosis

    2:15pm